Lupus Nephritis (LN) is an inflammation of the kidneys in individuals who have lupus or systemic lupus erythematosus (SLE).
Signs of LN are often present at the time of the diagnosis of lupus. Kidney problems commonly develop during the course of the disease.
If not diagnosed and treated early enough, LN can lead to significant illness. The implications of LN without treatment can be severe. It is vital that kidney function is preserved and maintained with a strict and regular regime of treatment.
The Tulip LN-1 Study is a clinical research study for active LN. It is part of a series of research studies, called the Tulip program, which are evaluating an investigational drug for lupus. The purpose of the Tulip LN-1 Study is to find out how well the study drug, which is called anifrolumab, treats the symptoms of active LN when it is given with other standard-of-care medications for the treatment of LN.
Your role in the Tulip LN-1 Study:
- If you decide to join the Tulip LN-1 Study, the study will last up to 64 weeks.
- There will be up to 17 scheduled clinic visits during this time.
- You will be randomized (like flipping a coin) to 1 of the 3 study-treatment groups.
- All participants will receive standard-of-care medications for LN. In addition, two-thirds of participants will receive anifrolumab and one-third will receive placebo.
- During your first study visit, you will be asked questions about your medical and surgical history and your general health, and will undergo several procedures so the study team can determine if you can take part in the study.
- Ask your physician about this study and for more information.
The study drug and study-related procedures will be provided at no cost to you.
To join the Tulip LN-1 Study you must:
- Be between the ages of 18 and 70 years
- Have active LN
- Be interested in trying an investigational drug for your LN.
There are other criteria to meet before you join the study. These are to determine whether you are eligible for the study, and whether the study is right for you.
If you would like to learn more about the Tulip LN-1 Study, please contact us @ 480-626-6656 or by email: email@example.com